Dawkins Sam, Hobson Alex R, Kalra Paul R, Tang Augustine T M, Monro James L, Dawkins Keith D
Wessex Cardiac Unit, Southampton University Hospital, Southampton, United Kingdom.
Ann Thorac Surg. 2008 Jan;85(1):108-12. doi: 10.1016/j.athoracsur.2007.08.024.
Conducting system defects are common in patients with aortic valve disease. Aortic valve replacement may result in further conduction abnormalities and necessitate permanent pacemaker implantation (PPM). We sought to identify the contemporary incidence and predictors for early postoperative PPM in patients undergoing isolated aortic valve replacement.
Data were analyzed from 354 consecutive patients undergoing isolated aortic valve replacement at a referral cardiac unit during a 30-month period; data were unavailable on 4 patients and a further 8 had undergone preoperative PPM. Results for the remaining 342 patients (97%; mean age, 67 +/- 14 years), of whom 212 were males, are presented. The major indications for aortic valve replacement were valvular stenosis (n = 224), regurgitation (n = 70), or infective endocarditis (n = 25). Preoperative conducting system disease was present in 26% of patients.
In-hospital mortality was 1.8% (6 of 342 patients). Postoperatively 29 patients (8.5%) required early PPM, of which 26 were during the index admission. Patients with preoperative conducting system disease (16% versus 6%; p = 0.004) and valvular regurgitation (16% versus 7%; p = 0.01) were more likely to require PPM as opposed to those without. Preoperative conducting system disease was the only independent predictor of PPM (p < 0.01); the relative risk of PPM requirement in this group was 2.88 (95% confidence interval, 1.31 to 6.33).
Permanent pacemaker implantation requirement after aortic valve replacement is a common occurrence, and should be discussed as part of the preoperative consent process. Preexisting conducting disease and preoperative aortic regurgitation were predictors of PPM requirement.
传导系统缺陷在主动脉瓣疾病患者中很常见。主动脉瓣置换术可能会导致进一步的传导异常,并需要植入永久性起搏器(PPM)。我们试图确定单纯主动脉瓣置换术患者术后早期PPM的当代发病率及预测因素。
对一家心脏专科转诊中心30个月内连续354例接受单纯主动脉瓣置换术的患者的数据进行分析;4例患者数据缺失,另有8例术前已植入PPM。本文呈现了其余342例患者(97%;平均年龄67±14岁)的结果,其中男性212例。主动脉瓣置换术的主要适应证为瓣膜狭窄(n = 224)、反流(n = 70)或感染性心内膜炎(n = 25)。26%的患者术前存在传导系统疾病。
住院死亡率为1.8%(342例患者中的6例)。术后29例患者(8.5%)需要早期PPM,其中26例在首次住院期间。与无术前传导系统疾病的患者相比,术前存在传导系统疾病的患者(16%对6%;p = 0.004)和瓣膜反流患者(16%对7%;p = 0.01)更有可能需要PPM。术前传导系统疾病是PPM的唯一独立预测因素(p < 0.01);该组患者需要PPM的相对风险为2.88(95%置信区间,1.31至6.33)。
主动脉瓣置换术后需要植入永久性起搏器很常见,应在术前知情同意过程中进行讨论。既往存在的传导疾病和术前主动脉反流是需要PPM的预测因素。